Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Trial of Conservative Management of Atypical Endometrial Hyperplasia and Well to Moderately Differentiated Endometrial Carcinoma Using Megestrol Acetate

NCT00483327 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00483327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Trial of Conservative Management of Atypical Endometrial Hyperplasia and Well to Moderately Differentiated Endometrial Carcinoma Using Megestrol Acetate
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2013
Enrollment
31 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, endometrial carcinoma